 WESTLAKE VILLAGE, Calif., June 3, 2021 PRNewswire -- MannKind Corporation Nasdaq: MNKD, which focuses on the development of innovative medicines for patients with endocrine and orphan lung diseases, announced today that it will present a poster Abstract 654 Topic AS09 New Insulin Delivery Systems: Inhaled, Transdermal, Implanted Devices at the 14th International Conference on Advanced Technologies Treatments for Diabetes ATTD 2021 to be held virtually, June 2-5. 